Strength
120 mg/1
Manufacturer
H2-Pharma LLCNDC
61269046090
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
ORLISTATApproval Type
New Drug (NDA)
FDA Application
NDA020766On Market Since
12/17/2010
Pharmacological Classes
Intestinal Lipase Inhibitor
Lipase Inhibitors
Related Drugs
Same classification
No related drugs found.